Celebrating a Mentor – College Honors Faculty Members With New Award Named for the Late Mavis Agbandje-McKenna, PhD
Mavis Agbandje-McKenna, PhD, a UF College of Medicine professor in the department of biochemistry and molecular biology and the director of the Center for Structural Biology, dedicated 32 years to advancing discoveries in adeno-associated viruses, or AAV, and other parvoviruses at UF before passing away in 2021. In addition to being a globally recognized parvovirus researcher, she demonstrated an unwavering commitment to training the next generation of scientists.
StrideBio Announces Closing of $81.5M Series B Financing
StrideBio, Inc., a leading developer of novel engineered adeno-associated virus (AAV) based gene therapies, announced the closing of an oversubscribed Series B funding round, which raised $81.5 million.
World-Renowned UF Health Biochemistry Researcher Mavis Agbandje-McKenna, Ph.D., Dies
University of Florida Health biochemistry professor Mavis Agbandje-McKenna, Ph.D., whose world-renowned work on the detailed structure of viruses led to advances in gene therapy treatments for different diseases, died Wednesday (March 3) at her home near Gainesville of the neurodegenerative disease amyotrophic lateral sclerosis.
UF Researcher Among 2020 ASGCT Award Recipients
Mavis Agbandje-McKenna, Ph.D., a professor of Biochemistry and Molecular Biology at the University of Florida College of Medicine, is among the winners... Read More
UF Health Researcher’s Gene Therapy Technique Being Further Developed to Treat Neurodegenerative Disorders
A gene therapy technique discovered by a University of Florida Health researcher and her colleague is now being used to develop treatments... Read More
